{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T19:20:41Z","timestamp":1773775241296,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F31DK115029"],"award-info":[{"award-number":["F31DK115029"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K24DK102057"],"award-info":[{"award-number":["K24DK102057"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014576","name":"Office of the President, University of California","doi-asserted-by":"publisher","award":["Dissertation-Year Award"],"award-info":[{"award-number":["Dissertation-Year Award"]}],"id":[{"id":"10.13039\/100014576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s11606-020-06426-5","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T08:35:32Z","timestamp":1611909332000},"page":"2648-2655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Predicting Non-Alcoholic Fatty Liver Disease for Adults Using Practical Clinical Measures: Evidence from the Multi-ethnic Study of Atherosclerosis"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9694-6842","authenticated-orcid":false,"given":"Luis A.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Shiboski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick T.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingzhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan D.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alka M.","family":"Kanaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"key":"6426_CR1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2337\/dc06-1539","volume":"30","author":"KG Tolman","year":"2007","unstructured":"Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease. Diabetes Care 2007; 30: 734\u201343.","journal-title":"Diabetes Care"},{"key":"6426_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73\u201384.","journal-title":"Hepatology"},{"key":"6426_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/MOG.0b013e32835ca11d","volume":"29","author":"ER Perito","year":"2013","unstructured":"Perito ER, Rodriguez LA, Lustig RH. Dietary treatment of nonalcoholic steatohepatitis. Curr Opin Gastroenterol 2013; 29: 170\u20136.","journal-title":"Curr Opin Gastroenterol"},{"key":"6426_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases: Hepatology, Vol. XX, No. X, 2017. Hepatology 2018; 67: 328\u201357.","journal-title":"Hepatology"},{"key":"6426_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1210\/er.2008-0009","volume":"29","author":"N Stefan","year":"2008","unstructured":"Stefan N, Kantartzis K, H\u00e4ring H-U. Causes and Metabolic Consequences of Fatty Liver. Endocr Rev 2008; 29: 939\u201360.","journal-title":"Endocr Rev"},{"key":"6426_CR6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017; 66: 1138\u201353.","journal-title":"Gut"},{"key":"6426_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/joim.12719","volume":"283","author":"P Dongiovanni","year":"2018","unstructured":"Dongiovanni P, Stender S, Pietrelli A, et al. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med 2018; 283: 356\u201370.","journal-title":"J Intern Med"},{"key":"6426_CR8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jgh.13264","volume":"31","author":"S Ballestri","year":"2016","unstructured":"Ballestri S, Zona S, Targher G, et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol 2016; 31: 936\u201344.","journal-title":"J Gastroenterol Hepatol"},{"key":"6426_CR9","doi-asserted-by":"publisher","unstructured":"Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut Published Online First: 16 September 2020. https:\/\/doi.org\/10.1136\/gutjnl-2020-322572.","DOI":"10.1136\/gutjnl-2020-322572"},{"key":"6426_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/CIRCRESAHA.119.316337","volume":"126","author":"J Cai","year":"2020","unstructured":"Cai J, Zhang X-J, Ji Y-X, Zhang P, She Z-G, Li H. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases. Circ Res 2020; 126: 679\u2013704.","journal-title":"Circ Res"},{"key":"6426_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2036.2010.04556.x","volume":"33","author":"JK Dowman","year":"2011","unstructured":"Dowman JK, Tomlinson JW, Newsome PN. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2011; 33: 525\u201340.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"6426_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"66","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 66(1):33.","journal-title":"BMC Gastroenterol"},{"key":"6426_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"J-H Lee","year":"2010","unstructured":"Lee J-H, Kim D, Kim HJ, et al. Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 2010; 42: 503\u20138.","journal-title":"Dig Liver Dis"},{"key":"6426_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen A, Peltonen M, Hakkarainen A, et al. Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors. Gastroenterology 2009; 137: 865\u201372.","journal-title":"Gastroenterology"},{"key":"6426_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1476-5926-4-10","volume":"4","author":"T Poynard","year":"2005","unstructured":"Poynard T, Ratziu V, Naveau S, et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005; 4: 10.","journal-title":"Comp Hepatol"},{"key":"6426_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/apt.14172","volume":"46","author":"TC-F Yip","year":"2017","unstructured":"Yip TC-F, Ma AJ, Wong VW-S, et al. Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population. Aliment Pharmacol Ther 2017; 46: 447\u201356.","journal-title":"Aliment Pharmacol Ther"},{"key":"6426_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-230X-10-98","volume":"10","author":"G Bedogni","year":"2010","unstructured":"Bedogni G, Kahn HS, Bellentani S, Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol 2010; 10: 98.","journal-title":"BMC Gastroenterol"},{"key":"6426_CR18","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler EM, Schouten JNL, Hansen BE, Hofman A, Stricker BH, Janssen HLA. External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study. Clin Gastroenterol Hepatol 2013; 11: 1201\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6426_CR19","doi-asserted-by":"crossref","unstructured":"Yang B-L, Wu W-C, Fang K-C, et al. External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan. Sookoian SC, ed. PLoS ONE 2015; 10: e0120443.","DOI":"10.1371\/journal.pone.0120443"},{"key":"6426_CR20","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/j.1478-3231.2011.02580.x","volume":"31","author":"JH Kim","year":"2011","unstructured":"Kim JH, Kwon SY, Lee SW, Lee CH. Validation of fatty liver index and lipid accumulation product for predicting fatty liver in Korean population: Letters to the Editor. Liver Int 2011; 31: 1600\u20131.","journal-title":"Liver Int"},{"key":"6426_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1530\/EJE-14-0112","volume":"171","author":"DJ Cuthbertson","year":"2014","unstructured":"Cuthbertson DJ, Weickert MO, Lythgoe D, et al. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. Eur J Endocrinol 2014; 171: 561\u20139.","journal-title":"Eur J Endocrinol"},{"key":"6426_CR22","doi-asserted-by":"publisher","first-page":"e1682","DOI":"10.1097\/MD.0000000000001682","volume":"94","author":"X Huang","year":"2015","unstructured":"Huang X, Xu M, Chen Y, et al. Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese: Medicine (Baltimore) 2015; 94: e1682.","journal-title":"Medicine (Baltimore)"},{"key":"6426_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/aje\/kwf113","volume":"156","author":"DE Bild","year":"2002","unstructured":"Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: Objectives and Design. Am J Epidemiol 2002; 156: 871\u201381.","journal-title":"Am J Epidemiol"},{"key":"6426_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.amjcard.2015.05.012","volume":"116","author":"GH Tison","year":"2015","unstructured":"Tison GH, Blaha MJ, Nasir K, et al. Relation of Anthropometric Obesity and Computed Tomography Measured Nonalcoholic Fatty Liver Disease (from the Multiethnic Study of Atherosclerosis). Am J Cardiol 2015; 116: 541\u20136.","journal-title":"Am J Cardiol"},{"key":"6426_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1148\/radiol.2341040439","volume":"234","author":"JJ Carr","year":"2005","unstructured":"Carr JJ, Nelson JC, Wong ND, et al. Calcified Coronary Artery Plaque Measurement with Cardiac CT in Population-based Studies: Standardized Protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) Study. Radiology 2005; 234: 35\u201343.","journal-title":"Radiology"},{"key":"6426_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0149-936X(81)90054-0","volume":"5","author":"GM Bydder","year":"1981","unstructured":"Bydder GM, Chapman RWG, Harry D, Bassan L, Sherlock S, Kreel L. Computed tomography attenuation values in fatty liver. J Comput Tomogr 1981; 5: 33\u20135.","journal-title":"J Comput Tomogr"},{"key":"6426_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.07.018","volume":"242","author":"RV Shah","year":"2015","unstructured":"Shah RV, Allison MA, Lima JAC, et al. Liver fat, statin use, and incident diabetes: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2015; 242: 211\u20137.","journal-title":"Atherosclerosis"},{"key":"6426_CR28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.acra.2012.02.022","volume":"19","author":"I Zeb","year":"2012","unstructured":"Zeb I, Li D, Nasir K, Katz R, Larijani VN, Budoff MJ. Computed Tomography Scans in the Evaluation of Fatty Liver Disease in a Population Based Study: The Multi-Ethnic Study of Atherosclerosis. Acad Radiol 2012; 19: 811\u20138.","journal-title":"Acad Radiol"},{"key":"6426_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2017","unstructured":"Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2017; 15: 11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6426_CR30","doi-asserted-by":"crossref","unstructured":"Le MH, Devaki P, Ha NB, et al. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. Yu M-L, ed. PLoS ONE 2017; 12: e0173499.","DOI":"10.1371\/journal.pone.0173499"},{"key":"6426_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KGMM Alberti","year":"2006","unstructured":"Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome\u2014a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469\u201380.","journal-title":"Diabet Med"},{"key":"6426_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/PSY.0b013e3180f61c5c","volume":"69","author":"SH Golden","year":"2007","unstructured":"Golden SH, Lee HB, Schreiner PJ, et al. Depression and Type 2 Diabetes Mellitus: The Multiethnic Study of Atherosclerosis: Psychosom Med 2007; 69: 529\u201336.","journal-title":"Psychosom Med"},{"key":"6426_CR33","unstructured":"Anon. WHO | Obesity: preventing and managing the global epidemic. 2000."},{"key":"6426_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"Consultation W expert","year":"2004","unstructured":"Consultation W expert. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157\u201363.","journal-title":"Lancet"},{"key":"6426_CR35","doi-asserted-by":"publisher","first-page":"814","DOI":"10.2337\/dc14-2071","volume":"38","author":"MRG Araneta","year":"2015","unstructured":"Araneta MRG, Kanaya AM, Hsu WC, et al. Optimum BMI Cut Points to Screen Asian Americans for Type 2 Diabetes. Diabetes Care 2015; 38: 814\u201320.","journal-title":"Diabetes Care"},{"key":"6426_CR36","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"LW Wilkins","year":"2002","unstructured":"Wilkins LW. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002; 106: 3143\u20133143.","journal-title":"Circulation"},{"key":"6426_CR37","doi-asserted-by":"crossref","unstructured":"Strobl C, Hothorn T, Zeileis A. Party on! A New, Conditional Variable Importance Measure for Random Forests Available in the party Package. The R Journal, 1(2):14\u201317. http:\/\/journal.R-project.org\/archive\/2009-2\/RJournal_2009-2_Strobl-et-al.pdf.","DOI":"10.32614\/RJ-2009-013"},{"key":"6426_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random Forests. Mach Learn 2001; 45: 5\u201332.","journal-title":"Mach Learn"},{"key":"6426_CR39","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/sim.1742","volume":"23","author":"LM Sullivan","year":"2004","unstructured":"Sullivan LM, Massaro JM, D\u2019Agostino RB. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med 2004; 23: 1631\u201360.","journal-title":"Stat Med"},{"key":"6426_CR40","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1097\/01.CCM.0000216702.94014.75","volume":"34","author":"DA Harrison","year":"2006","unstructured":"Harrison DA, Brady AR, Parry GJ, Carpenter JR, Rowan K. Recalibration of risk prediction models in a large multicenter cohort of admissions to adult, general critical care units in the United Kingdom*: Crit Care Med 2006; 34: 1378\u201388.","journal-title":"Crit Care Med"},{"key":"6426_CR41","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jclinepi.2009.11.009","volume":"63","author":"K Rufibach","year":"2010","unstructured":"Rufibach K. Use of Brier score to assess binary predictions. J Clin Epidemiol 2010; 63: 938\u20139.","journal-title":"J Clin Epidemiol"},{"key":"6426_CR42","unstructured":"Goldstein BA, Navar AM, Carter RE. Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges. Eur Heart J 2017 Jun 14;38(23):1805-14."},{"key":"6426_CR43","doi-asserted-by":"crossref","unstructured":"Long MT, Pedley A, Massaro JM, et al. A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study. Liver Int 2018 Aug;38(8):1495-503.","DOI":"10.1111\/liv.13709"},{"key":"6426_CR44","doi-asserted-by":"publisher","first-page":"14185","DOI":"10.3748\/wjg.v20.i39.14185","volume":"20","author":"M Bertolotti","year":"2014","unstructured":"Bertolotti M. Nonalcoholic fatty liver disease and aging: Epidemiology to management. World J Gastroenterol 2014; 20: 14185.","journal-title":"World J Gastroenterol"},{"key":"6426_CR45","first-page":"1388","volume":"64","author":"Anon","year":"2016","unstructured":"Anon. EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016; 64: 1388\u2013402.","journal-title":"J Hepatol"},{"key":"6426_CR46","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.2337\/dc19-S004","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes\u20142019. Diabetes Care 2019; 42: S34\u2013S45.","journal-title":"Diabetes Care"},{"key":"6426_CR47","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11901-019-00497-7","volume":"18","author":"C Caussy","year":"2019","unstructured":"Caussy C. Should We Screen High-Risk Populations for NAFLD? Curr Hepatol Rep 2019; 18: 433\u201343.","journal-title":"Curr Hepatol Rep"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06426-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-020-06426-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06426-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T01:09:12Z","timestamp":1643159352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-020-06426-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["6426"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-06426-5","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,26]]},"assertion":[{"value":"28 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, or of the University of California.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}